¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦57ȸ ±¹Á¦ÀÓ»ó½Ã°¢Àü±â»ý¸®ÇÐȸ ½ÉÆ÷Áö¾ö : 2019-10-09

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦57ȸ ±¹Á¦ÀÓ»ó½Ã°¢Àü±â»ý¸®ÇÐȸ ½ÉÆ÷Áö¾ö : 2019-10-09
±³À°ÀÏÀÚ : 2019-10-09
±³À°Àå¼Ò : Grand Ambassador Hotel 2F Grand Ballroom  
±³À°ÁÖÁ¦ : Á¦57ȸ ±¹Á¦ÀÓ»ó½Ã°¢Àü±â»ý¸®ÇÐȸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹ÀÓ»ó½Ã°¢Àü±â»ý¸®ÇÐȸ  
´ã´çÀÚ : ±èÈƵ¿
¿¬¶ôó : 02-2273-7650  
À̸ÞÀÏ : rio1010@hanmail.net      
±³À°Á¾·ù : ¾È°ú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 250,000¿ø      
ºñ°í ÀϹݵî·Ï(Àü¹®ÀÇ) 150,000 / Çлý(Àü°øÀÇ) 50,000 / º´¿ø°ü°èÀÚ 50,000 / Human Course 250,000 / Animal Course 250,000 / ÇöÀåµî·Ï 200,000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-09  09:00~09:10 East Asia Inherited Retinal Disease Studies; Clinical and Genetic Characteristics of Inherited Retinal Disease in Korean Population.  Se Joon Woo(Seoul National University Bundang Hospital, South Korea) 
±³À°½Ã°£ 10-09  09:10~09:20 Multimodal imaging of East Asian Patients with Occult Macular Dystrophy (Miyake¡¯s disease): EAOMD Report No. 3  Kwangsic Joo(Seoul National University Bundang Hospital, South Korea) 
±³À°½Ã°£ 10-09  09:20~09:30 Clinical and Genetic Characteristics of East Asian Patients with Stargardt disease: East Asia Stargardt Studies (EAStar) Report 1  Xiao Liu(Tokyo Medical Center, Tokyo, Japan) 
±³À°½Ã°£ 10-09  09:30~09:40 East Asia Inherited Retinal Disease Studies: Clinical and Genetic Characteristics of Inherited Retinal Disease in South West Population.  Shiying Li(Southwest Hospital, China) 
±³À°½Ã°£ 10-09  09:40~09:50 East Asia Inherited Retinal Disease Studies; Clinical and Genetic Characteristics of Inherited Retinal Disease in Japanese Population.  Kaoru Fujinami(Tokyo Medical Center, Tokyo, Japan) 
±³À°½Ã°£ 10-09  09:50~10:00 Clinical and Genetic Characteristics of East Asian Patients with Occult Macular Dystrophy (Miyake¡¯s disease); EAOMD Report No.1 and 2  Lizhu Yang(Tokyo Medical Center, Tokyo, Japan) 
±³À°½Ã°£ 10-09  10:00~10:10 Spectrum of Occult Macular Dystrophy: Investigation of RP1L1 Positive and RP1L1 Negative OMD; EAOMD Report 5  Lizhu Yang(Tokyo Medical Center, Tokyo, Japan) 
±³À°½Ã°£ 10-09  10:10~10:20 East Asia Inherited Retinal Disease Studies; Clinical and Genetic Characteristics of Inherited Retinal Disease in a Large Chinese Cohort in Peking Union Medical College Hospital  Ruifang Sui(Peking Union Medical College Hospital, China) 
È޽Ġ10-09  10:20~10:45 Coffee break  Coffee break(Coffee break) 
±³À°½Ã°£ 10-09  10:45~11:30 Genetic screening and clinical characterization for inherited retinal disease  Hyeong Gon Yu(Seoul National University Hospital, South Korea) 
±³À°½Ã°£ 10-09  11:30~11:45 Clinical and Genetic Characterization of Chinese Patients with Choroideremia  Ruifang Sui(Peking Union Medical College Hospital, China) 
±³À°½Ã°£ 10-09  11:45~12:00 The structural and full-field ERG features of PDE6C-associated achromatopsia  Anthony G Robson(Morrfields Eye Hospital, UK) 
±³À°½Ã°£ 10-09  12:00~12:15 Functional change in different categories of Stargardt¡¯s diseases£º2 years follow-up of human embryonic stem cell-derived retinal pigment epithelial cells transplantation  Shi Ying LI(Southwest HospitaL, Third Military Medical University, China) 
±³À°½Ã°£ 10-09  12:15~12:30 Protein Logistics Disease  Regine L. Muehlfriedel(Institute for Ophthalmic Research, Germany) 
±³À°½Ã°£ 10-09  12:30~12:45 Towards the Understanding of Retinal Degeneration in Phosphodiesterase 6 (PDE6) Deficiency  Mathias W. Seeliger(Institute for Ophthalmic Research, Germany) 
±³À°½Ã°£ 10-09  12:45~13:00 Tracking panretinal scotopic dark adaptation dynamically with the electroretinogram: slowed recovery in Sorsby Fundus Dystrophy  Xiaofan Jiang(UCL Institute of Ophthalmology, UK) 
½Ä»ç 10-09  13:00~14:00 Lunch  Lunch(Lunch) 
±³À°½Ã°£ 10-09  14:00~14:15 Impaired mf ERG is associated with suspected cone loss on adaptive optics in patients treated with hydroxychloroquine  Carl Arndt(Université Reims Champagne Ardenne, France) 
±³À°½Ã°£ 10-09  14:15~14:30 Retinal dysfunction at the macula in patients with a ¡°macula-on¡± rhegmatogenous retinal detachment: evaluation of the photopic negative response  Kunihiko Akiyama(Tokyo Medical Center, Japan) 
±³À°½Ã°£ 10-09  14:30~14:45 Visual Field and Electroretinogram in Birdshot Choroiretinopathy  Hossein Ameri(University of Southern California, USA) 
±³À°½Ã°£ 10-09  14:45~15:00 Clinical course of paraneoplastic retinopathy with anti-TRPM1 autoantibody in Japanese cohort  Shinji Ueno(Nagoya University, Japan) 
±³À°½Ã°£ 10-09  15:00~15:15 A NOVEL MULTIFOCAL ELECTRORETINOGRAPHY STIMULUS FOR DETECTING HYDROXYCHLOROQUINE RETINAL TOXICITY  Stuart Coupland(University of Ottawa, Canada) 
±³À°½Ã°£ 10-09  15:15~15:30 Changes of flicker ERGs before and after three monthly intravitreal ranibizumab injections in eyes with central retinal vein occlusion  Mineo Kondo(Mie University, Japan) 
È޽Ġ10-09  15:30~16:00 Coffee break  Coffee break(Coffee break) 
±³À°½Ã°£ 10-09  16:00~16:15 Electrophysiological assessment of cone photoreceptor and inner-retina abnormalities in early-stage diabetic retinopathy  J. Jason McAnany(University of Illinois at Chicago, USA) 
±³À°½Ã°£ 10-09  16:15~16:30 The Photopic Hill in Intravitreal Ranibizumab and Panretinal Photocoagulation for Proliferative Diabetic Retinopathy  Andre Messias(University of São Paulo, Brazil) 
±³À°½Ã°£ 10-09  16:30~16:45 Correlations between Multifocal Electroretinogram and Optical Coherence Tomography Angiography in the Diabetic Retinopathy Patients  Hoon Dong Kim(Soonchunhyang University, Korea) 
±³À°½Ã°£ 10-09  16:45~17:00 Predictive Value of the Flicker ERG in Patients with Diabetic Retinopathy  Mitchell Brigell(LKC Technologies, USA) 
±³À°½Ã°£ 10-09  17:00~17:15 Peripheral Pattern ERG in Diabetic Retinopathy: Early Evidence for Clinical Relevance  Shresta Patangay(University of Illinois at Chicago, USA) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦57ȸ ±¹Á¦ÀÓ»ó½Ã°¢Àü±â»ý¸®ÇÐȸ ½ÉÆ÷Áö¾ö : 2019-10-09""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2019 ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ Ãß°è ½ÉÆ÷Áö¾ö : 2019-10-10
´ÙÀ½±Û Á¦57ȸ ±¹Á¦ÀÓ»ó½Ã°¢Àü±â»ý¸®ÇÐȸ ½ÉÆ÷Áö¾ö : 2019-10-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
15 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-29 0 688 2018-07-28
14 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø ¿µ»óȹµæÀÇ ±â¼úÀû Ãø¸é°ú Æó¾Ï °ËÁø : 2018-07-29 0 733 2018-07-28
13 ¼­¿ï ´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29 0 861 2018-07-28
12 ¼­¿ï ´ëÇÑ¿µ»óÀÇÇÐȸ »ó±ÙÀÇ»ç À¯¹æÃÔ¿µ¿ëÀåÄ¡ Ç°Áú°ü¸® ±³À° 3ÀÏÂ÷(7¿ù29ÀÏ) : 2018-07-29 0 796 2018-07-28
11 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-29 0 813 2018-07-28
10 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 18 ȸ ü°èÀû ¹®Çå °íÂû[¸ÞŸºÐ¼®]À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2018-07-28 0 1,146 2018-07-28
9 °æ±â ¸íÁöº´¿ø ¿äÃò ¹× ½½°üÀý ÅëÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-07-28 0 1,100 2018-07-28
8 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-28 0 1,056 2018-07-28
7 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-07-28 0 982 2018-07-28
6 °æ±â ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ 2018 Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC) Symposium : 2018-07-28 0 1,226 2018-07-28
5 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hyperhidrosis Symposium : 2018-07-28 0 1,514 2018-07-28
4 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø 2018 The 11th Catholic Neurosurgery Update Symposium : 2018-07-28 0 1,389 2018-07-28
3 °æ±â ´ëÇÑ´ç´¢º´ÇÐȸ °æÀÎÁöȸEGDM (Essential Guideline to Diabetes Management) : 2018-07-28 0 2,201 2018-07-28
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,424 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 1,977 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷